Susquehanna International Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $847K | Sell |
|
|||||
|
2025
Q2 | $561K | Sell |
|
|||||
|
2025
Q1 | $557K | Sell |
|
|||||
|
2024
Q4 | $683K | Buy |
|
|||||
|
2024
Q3 | $252K | Sell |
|
|||||
|
2024
Q2 | $144K | Buy |
|
|||||
|
2024
Q1 | $198K | Sell |
|
|||||
|
2023
Q4 | $435K | Buy |
|
|||||
|
2023
Q3 | $268K | Sell |
|
|||||
|
2023
Q2 | $1M | Buy |
|
|||||
|
2023
Q1 | $220K | Sell |
|
|||||
|
2022
Q4 | $301K | Buy |
|
|||||
|
2022
Q3 | $140K | Sell |
|
|||||
|
2022
Q2 | $353K | Buy |
|
|||||
|
2022
Q1 | $575K | Sell |
|
|||||
|
2021
Q4 | $1.38M | Buy |
|
|||||
|
2021
Q3 | $1.44M | Sell |
|
|||||
|
2021
Q2 | $2.05M | Buy |
|
|||||
|
2021
Q1 | $959K | Buy |
|
|||||
|
2020
Q4 | $720K | Sell |
|
|||||
|
2020
Q3 | $706K | Buy |
|
|||||
|
2020
Q2 | $138K | Sell |
|
|||||
|
2020
Q1 | $130K | Buy |
|
|||||
|
2019
Q4 | $74K | Sell |
|
|||||
|
2019
Q3 | $173K | Sell |
|
|||||
|
2019
Q2 | $350K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $477K | Buy |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $204K | Buy |
|
|||||
|
2017
Q3 | $48K | Sell |
|
|||||
|
2017
Q2 | $320K | Buy |
|
|||||
|
2017
Q1 | $194K | Sell |
|
|||||
|
2016
Q4 | $529K | Buy |
|
|||||
|
2016
Q3 | $230K | Sell |
|
|||||
|
2016
Q2 | $251K | Buy |
|
|||||
|
2016
Q1 | $66K | Buy |
|
|||||
|
2015
Q4 | $76K | Buy |
|
|||||
|
2015
Q3 | $42K | Sell |
|
|||||
|
2015
Q2 | $182K | Buy |
|
|||||
|
2015
Q1 | $148K | Buy |
|
|||||
|
2014
Q4 | $65K | Sell |
|
|||||
|
2014
Q3 | $62K | Sell |
|
|||||
|
2014
Q2 | $185K | Buy |
|
|||||
|
2014
Q1 | $177K | Sell |
|
|||||
|
2013
Q4 | $825K | Buy |
|
|||||
|
2013
Q3 | $98K | Sell |
|
|||||
|
2013
Q2 | $127K | Buy |
|